Vu L. Truong - 18 Sep 2023 Form 4 Insider Report for Aridis Pharmaceuticals, Inc.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARDS	Stock Options	Award	$0	+30,000	+3.8%	$0.000000	817,750	18 Sep 2023	Common Stock	30,000	$0.0800	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	50% of the options vest on the date of grant and 2,500 vest on a monthly basis thereafter for six months.